News Release Details
Entegris Reports Solid Results in Third Quarter of 2018
- Record third-quarter revenue of
$398.6 million grew 15% from prior year - GAAP net income per diluted share of
$0.34 increased 21% from a year ago - Non-GAAP net income per diluted share of
$0.46 increased 15% from a year ago
Third-quarter sales were
For the first nine months of fiscal 2018, sales of
Mr. Loy added: "Our unique capability to address the industry's increasing materials complexity and purity challenges is driving our long-term growth prospects and our ability to outperform the market. For the full year 2018 we expect to leverage our sales growth of approximately 15 percent into growth of our non-GAAP earnings per share of approximately 30 percent."
Quarterly Financial Results Summary
(in thousands, except
per share data)
GAAP Results | Q3-2018 | Q3-2017 | Q2-2018 | |||||||
Net sales | $398,597 | $345,591 | $383,059 | |||||||
Operating income | $67,975 | $60,655 | $74,933 | |||||||
Operating margin | 17.1% | 17.6 | % | 19.6% | ||||||
Net income | $48,060 | $40,902 | $54,349 | |||||||
Diluted earnings per share (EPS) | $0.34 | $0.28 | $0.38 | |||||||
Non-GAAP Results | ||||||||||
Non-GAAP adjusted operating income | $93,893 | $81,077 | $93,473 | |||||||
Non-GAAP adjusted operating margin | 23.6% | 23.5 | % | 24.4% | ||||||
Non-GAAP net income | $65,621 | $56,989 | $69,835 | |||||||
Non-GAAP EPS | $0.46 | $0.40 | $0.49 |
Fourth-Quarter Outlook
For the fourth quarter ending
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Third-Quarter Results Conference Call Details
The call can also be accessed live and on-demand from the
Management’s slide presentation concerning the results for the third quarter, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.
ABOUT
Non-GAAP Information
The Company’s condensed consolidated
financial statements are prepared in conformity with accounting
principles generally accepted in
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. The words “believe,” “expect,”
“anticipate,” “intends,” “estimate,” “forecast,” “project,” “should,”
“may,” “will,” “would” or the negative thereof and similar expressions
are intended to identify such forward-looking statements. These
forward-looking statements include statements related to future period
guidance; future sales, net income, net income per diluted share,
non-GAAP EPS, non-GAAP net income, expenses and other financial metrics;
our performance relative to our markets; market and technology trends;
the development of new products and the success of their introductions;
Company's capital allocation strategy, which may be modified at any time
for any reason, including share repurchases, dividends, debt repayments
and potential acquisitions; the effect of the Tax Cuts and Jobs Act on
our capital allocation strategy; the impact of the acquisitions we have
made and commercial partnerships we have established; our ability to
execute on our strategies; and other matters. These statements involve
risks and uncertainties, and actual results may differ. These risks and
uncertainties include, but are not limited to, weakening of global
and/or regional economic conditions, generally or specifically in the
semiconductor industry, which could decrease the demand for our products
and solutions; our ability to meet rapid demand shifts; our ability to
continue technological innovation and introduce new products to meet our
customers' rapidly changing requirements; our concentrated customer
base; our ability to identify, effect and integrate acquisitions, joint
ventures or other transactions; our ability to protect and enforce
intellectual property rights; operational, political and legal risks of
our international operations; our dependence on sole source and limited
source suppliers; the increasing complexity of certain manufacturing
processes; raw material shortages and price increases; changes in
government regulations of the countries in which we operate; fluctuation
of currency exchange rates; fluctuations in the market price of
Entegris’ stock; the level of, and obligations associated with, our
indebtedness; and other risk factors and additional information
described in our filings with the
Entegris, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||||||||
Three months ended | |||||||||
September 29, 2018 | September 30, 2017 | June 30, 2018 | |||||||
Net sales | $398,597 | $345,591 | $383,059 | ||||||
Cost of sales | 216,881 | 190,184 | 200,681 | ||||||
Gross profit | 181,716 | 155,407 | 182,378 | ||||||
Selling, general and administrative expenses | 62,358 | 57,699 | 65,200 | ||||||
Engineering, research and development expenses | 29,964 | 26,002 | 30,231 | ||||||
Amortization of intangible assets | 21,419 | 11,051 | 12,014 | ||||||
Operating income | 67,975 | 60,655 | 74,933 | ||||||
Interest expense, net | 7,678 | 7,599 | 6,925 | ||||||
Other expense, net | 810 | 2,906 | 3,877 | ||||||
Income before income tax expense | 59,487 | 50,150 | 64,131 | ||||||
Income tax expense | 11,427 | 9,248 | 9,782 | ||||||
Net income | $48,060 | $40,902 | $54,349 | ||||||
Basic net income per common share: | $0.34 | $0.29 | $0.38 | ||||||
Diluted net income per common share: | $0.34 | $0.28 | $0.38 | ||||||
Cash dividends declared per common share: | $0.07 | — | $0.07 | ||||||
Weighted average shares outstanding: | |||||||||
Basic | 141,556 | 141,684 | 141,701 | ||||||
Diluted | 143,033 | 143,594 | 143,238 | ||||||
Entegris, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
||||||
Nine months ended | ||||||
September 29, 2018 | September 30, 2017 | |||||
Net sales | $1,148,855 | $991,970 | ||||
Cost of sales | 608,764 | 546,664 | ||||
Gross profit | 540,091 | 445,306 | ||||
Selling, general and administrative expenses | 185,827 | 161,176 | ||||
Engineering, research and development expenses | 87,781 | 80,462 | ||||
Amortization of intangible assets | 45,102 | 33,003 | ||||
Operating income | 221,381 | 170,665 | ||||
Interest expense, net | 21,829 | 24,095 | ||||
Other expense, net |
4,826 | 3,762 | ||||
Income before income tax expense | 194,726 | 142,808 | ||||
Income tax expense | 34,755 | 29,401 | ||||
Net income | $159,971 | $113,407 | ||||
Basic net income per common share: | $1.13 | $0.80 | ||||
Diluted net income per common share: | $1.12 | $0.79 | ||||
Cash dividends declared per common share: | $0.21 | — | ||||
Weighted average shares outstanding: | ||||||
Basic | 141,613 | 141,627 | ||||
Diluted | 143,308 | 143,472 | ||||
Entegris, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||||||
September 29, 2018 | December 31, 2017 | |||||
ASSETS | ||||||
Cash and cash equivalents | $294,893 | $625,408 | ||||
Accounts receivable, net | 212,729 | 183,434 | ||||
Inventories | 264,090 | 198,089 | ||||
Deferred tax charges and refundable income taxes | 25,191 | 18,012 | ||||
Other current assets | 24,043 | 32,665 | ||||
Total current assets | 820,946 | 1,057,608 | ||||
Property, plant and equipment, net | 393,706 | 359,523 | ||||
Goodwill | 542,235 | 359,688 | ||||
Intangible assets | 323,379 | 182,430 | ||||
Deferred tax assets | 11,735 | 9,103 | ||||
Other assets | 11,455 | 7,820 | ||||
Total assets | $2,103,456 | $1,976,172 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||
Long-term debt, current maturities | — | $100,000 | ||||
Accounts payable | 74,590 | 68,762 | ||||
Accrued liabilities | 116,285 | 99,374 | ||||
Income tax payable | 20,137 | 22,835 | ||||
Total current liabilities | 211,012 | 290,971 | ||||
Long-term debt, excluding current maturities | 650,625 | 574,380 | ||||
Other liabilities | 158,148 | 117,803 | ||||
Shareholders’ equity | 1,083,671 | 993,018 | ||||
Total liabilities and shareholders’ equity | $2,103,456 | $1,976,172 | ||||
Entegris, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
||||||||||||
Three months ended | Nine months ended | |||||||||||
September 29, |
September 30, |
September 29, |
September 30, |
|||||||||
Operating activities: | ||||||||||||
Net income | $48,060 | $40,902 | $159,971 | $113,407 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Depreciation | 16,537 | 14,785 | 48,236 | 43,173 | ||||||||
Amortization | 21,419 | 11,051 | 45,102 | 33,003 | ||||||||
Stock-based compensation expense | 4,170 | 3,548 | 12,727 | 11,457 | ||||||||
Provision for deferred income taxes | 691 | (2,953) | (1,066) | 254 | ||||||||
Other | 5,944 | 13,898 | 10,584 | 24,028 | ||||||||
Changes in operating assets and liabilities: | ||||||||||||
Trade accounts and notes receivable | (11,400) | (12,313) | (8,713) | (15,345) | ||||||||
Inventories | (6,316) | (1,047) | (28,788) | (14,884) | ||||||||
Accounts payable and accrued liabilities | 5,526 | 20,911 | (9,440) | 7,598 | ||||||||
Income taxes payable and refundable income taxes | (1,678) | (1,293) | (9,193) | 1,664 | ||||||||
Other | 1,190 | 1,552 | 1,829 | 3,277 | ||||||||
Net cash provided by operating activities | 84,143 | 89,041 | 221,249 | 207,632 | ||||||||
Investing activities: | ||||||||||||
Acquisition of property and equipment | (27,900) | (25,447) | (75,337) | (67,939) | ||||||||
Acquisition of businesses, net of cash acquired | (43) | (380,268) | (20,000) | |||||||||
Other | 3,109 | 863 | 5,014 | 1,074 | ||||||||
Net cash used in investing activities | (24,834) | (24,584) | (450,591) | (86,865) | ||||||||
Financing activities: | ||||||||||||
Payments on long-term debt | — | (25,000) | (27,000) | (75,000) | ||||||||
Issuance of common stock | 2 | 677 | 3,029 | 3,582 | ||||||||
Taxes paid related to net share settlement of equity awards | (139) | (168) | (14,552) | (5,407) | ||||||||
Repurchase and retirement of common stock | (10,000) | (10,000) | (30,000) | (18,000) | ||||||||
Dividend payments | (9,899) | — | (29,701) | — | ||||||||
Other | (250) | 1,254 | (1,270) | |||||||||
Net cash used in financing activities | (20,286) | (34,491) | (96,970) | (96,095) | ||||||||
Effect of exchange rate changes on cash | (1,236) | (404) | (4,203) | 4,136 | ||||||||
Increase (Decrease) in cash and cash equivalents | 37,787 | 29,562 | (330,515) | 28,808 | ||||||||
Cash and cash equivalents at beginning of period | 257,106 | 405,635 | 625,408 | 406,389 | ||||||||
Cash and cash equivalents at end of period | $294,893 | $435,197 | $294,893 | $435,197 | ||||||||
Entegris, Inc. and Subsidiaries Segment Information (In thousands) (Unaudited) |
|||||||||||||||
Three months ended | Nine months ended | ||||||||||||||
Net sales | September 29, 2018 | September 30, 2017 | June 30, 2018 | September 29, 2018 | September 30, 2017 | ||||||||||
Specialty Chemicals and Engineered Materials | $131,234 | $124,522 | $134,336 | $396,313 | $360,131 | ||||||||||
Microcontamination Control | 151,345 | 116,113 | 124,681 | 394,663 | 320,575 | ||||||||||
Advanced Materials Handling | 116,018 | 104,956 | 124,042 | 357,879 | 311,264 | ||||||||||
Total net sales | $398,597 | $345,591 | $383,059 | $1,148,855 | $991,970 |
Three months ended | Nine months ended | ||||||||||||||
Segment profit1 | September 29, 2018 | September 30, 2017 | June 30, 2018 | September 29, 2018 | September 30, 2017 | ||||||||||
Specialty Chemicals and Engineered Materials | $31,860 | $29,539 | $37,316 | $100,738 | $81,727 | ||||||||||
Microcontamination Control | 44,530 | 39,302 | 39,054 | 125,575 | 102,085 | ||||||||||
Advanced Materials Handling | 19,494 | 12,483 | 23,114 | 65,750 | 41,612 | ||||||||||
Total segment profit | 95,884 | 81,324 | 99,484 | 292,063 | 225,424 | ||||||||||
Amortization of intangibles | 21,419 | 11,051 | 12,014 | 45,102 | 33,003 | ||||||||||
Unallocated expenses | 6,490 | 9,618 | 12,537 | 25,580 | 21,756 | ||||||||||
Total operating income | $67,975 | $60,655 | $74,933 | $221,381 | $170,665 | ||||||||||
1Beginning in the first quarter of 2018, the Company has changed its definition of segment profit to include an allocation of certain general and administrative costs for the Company’s human resources, finance and information technology functions previously unallocated by the Company. Prior quarter information was recast to reflect the change in the Company's definition of segment profit.
Entegris, Inc. and Subsidiaries Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (In thousands) (Unaudited) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
September 29, |
September 30, |
June 30, 2018 |
September |
September |
||||||||||||
Net sales | $398,597 | $345,591 | $383,059 | $1,148,855 | $991,970 | |||||||||||
Gross profit-GAAP | $181,716 | $155,407 | $182,378 | $540,091 | $445,306 | |||||||||||
Adjustments to gross profit: | ||||||||||||||||
Severance related to organizational realignment | — | 740 | — | — | 740 | |||||||||||
Charge for fair value mark-up of acquired inventory sold | 3,281 | — | 208 | 3,489 | — | |||||||||||
Impairment of equipment | — | 3,364 | — | — | 5,330 | |||||||||||
Adjusted gross profit | $184,997 | $159,511 | $182,586 | $543,580 | $451,376 | |||||||||||
Gross margin - as a % of net sales | 45.6% | 45.0% | 47.6% | 47.0% | 44.9% | |||||||||||
Adjusted gross margin - as a % of net sales | 46.4% | 46.2% | 47.7% | 47.3% | 45.5% | |||||||||||
Entegris, Inc. and Subsidiaries Reconciliation of GAAP Segment Profit to Adjusted Operating Income (In thousands) (Unaudited) |
|||||||||||||||
Three months ended | Nine months ended | ||||||||||||||
Segment profit-GAAP |
September 29, |
September 30, |
June 30, 2018 |
September 29, |
September 30, |
||||||||||
Specialty Chemicals and Engineered Materials | $31,860 | $29,539 | $37,316 | $100,738 | $81,727 | ||||||||||
Microcontamination Control | 44,530 | 39,302 | 39,054 | 125,575 | 102,085 | ||||||||||
Advanced Materials Handling | 19,494 | 12,483 | 23,114 | 65,750 | 41,612 | ||||||||||
Total segment profit | 95,884 | 81,324 | 99,484 | 292,063 | 225,424 | ||||||||||
Amortization of intangible assets | 21,419 | 11,051 | 12,014 | 45,102 | 33,003 | ||||||||||
Unallocated expenses | 6,490 | 9,618 | 12,537 | 25,580 | 21,756 | ||||||||||
Total operating income | $67,975 | $60,655 | $74,933 | $221,381 | $170,665 | ||||||||||
Three months ended | Nine months ended | ||||||||||||||
Adjusted segment profit |
September 29, |
September 30, |
June 30, 2018 |
September 29, |
September 30, |
||||||||||
Specialty Chemicals and Engineered Materials1 | $31,860 | $29,553 | $37,316 | $100,738 | $81,741 | ||||||||||
Microcontamination Control 2 | 47,811 | 39,498 | 39,262 | 129,064 | 103,724 | ||||||||||
Advanced Materials Handling 3 | 19,960 | 17,704 | 23,114 | 66,216 | 49,119 | ||||||||||
Total adjusted segment profit | 99,631 | 86,755 | 99,692 | 296,018 | 234,584 | ||||||||||
Amortization of intangible assets4 | — | — | — | — | — | ||||||||||
Unallocated expenses5 | 5,738 | 5,678 | 6,219 | 18,510 | 17,816 | ||||||||||
Total adjusted operating income | $93,893 | $81,077 | $93,473 | $277,508 | $216,768 | ||||||||||
1Adjusted segment profit for Specialty Chemicals and
Engineered Materials for the three months and nine months ended
2Adjusted segment
profit for Microcontamination Control for the three months ended
3
Adjusted segment profit for Advanced Material Handling excludes
loss on sale of subsidiary of
4
Adjusted amortization of intangible assets excludes amortization
expense of
5 Adjusted unallocated
expenses for the three months ended
Adjusted unallocated
expenses for the nine months ended
Entegris, Inc. and Subsidiaries Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA (In thousands) (Unaudited) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
September 29, |
September 30, |
June 30, 2018 |
September |
September |
||||||||||||
Net sales | $398,597 | $345,591 | $383,059 | $1,148,855 | $991,970 | |||||||||||
Net income | $48,060 | $40,902 | $54,349 | $159,971 | $113,407 | |||||||||||
Adjustments to net income: | ||||||||||||||||
Income tax expense | 11,427 | 9,248 | 9,782 | 34,755 | 29,401 | |||||||||||
Interest expense, net | 7,678 | 7,599 | 6,925 | 21,829 | 24,095 | |||||||||||
Other expense, net | 810 | 2,906 | 3,877 | 4,826 | 3,762 | |||||||||||
GAAP - Operating income | 67,975 | 60,655 | 74,933 | 221,381 | 170,665 | |||||||||||
Charge for fair value write-up of acquired inventory sold | 3,281 | — | 208 | 3,489 | — | |||||||||||
Deal Costs | — | — | 5,121 | 5,121 | — | |||||||||||
Integration Costs | 752 | — | 1,197 | 1,949 | — | |||||||||||
Severance | — | 2,141 | — | — | 2,700 | |||||||||||
Impairment of equipment and intangibles1 | — | 7,230 | — | — | 10,400 | |||||||||||
Loss on sale of subsidiary | 466 | — | — | 466 | — | |||||||||||
Amortization of intangible assets | 21,419 | 11,051 | 12,014 | 45,102 | 33,003 | |||||||||||
Adjusted operating income | 93,893 | 81,077 | 93,473 | 277,508 | 216,768 | |||||||||||
Depreciation | 16,537 | 14,785 | 15,802 | 48,236 | 43,173 | |||||||||||
Adjusted EBITDA | $110,430 | $95,862 | $109,275 | $325,744 | $259,941 | |||||||||||
Adjusted operating margin | 23.6% | 23.5% | 24.4% | 24.2% | 21.9% | |||||||||||
Adjusted EBITDA - as a % of net sales | 27.7% | 27.7% | 28.5% | 28.4% | 26.2% | |||||||||||
1 Includes product line impairment charges of
Includes Jetalon intangible impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
Entegris, Inc. and Subsidiaries Reconciliation of GAAP Net Income to Non-GAAP Earnings per Share (In thousands, except per share data) (Unaudited) |
||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||
September 29, |
September 30, |
June 30, 2018 |
September |
September |
||||||||||||
GAAP net income | $48,060 | $40,902 | $54,349 | $159,971 | $113,407 | |||||||||||
Adjustments to net income: | ||||||||||||||||
Charge for fair value write-up of acquired inventory sold | 3,281 | — | 208 | 3,489 | — | |||||||||||
Deal Costs | — | — | 5,121 | 5,121 | — | |||||||||||
Integration Costs | 752 | — | 1,197 | 1,949 | — | |||||||||||
Severance | — | 2,141 | — | — | 2,700 | |||||||||||
Impairment of equipment and intangibles1 | — | 10,030 | — | — | 13,200 | |||||||||||
Loss on sale of subsidiary | 466 | — | — | 466 | — | |||||||||||
Amortization of intangible assets | 21,419 | 11,051 | 12,014 | 45,102 | 33,003 | |||||||||||
Tax effect of adjustments to net income and discrete items2 | (5,797) | (7,135) | (3,702) | (12,209) | (15,661) | |||||||||||
Tax effect of Tax Cuts and Jobs Act | (2,560) | — | $648 | (418) | — | |||||||||||
Non-GAAP net income | $65,621 | $56,989 | $69,835 | $203,471 | $146,649 | |||||||||||
Diluted earnings per common share | $0.34 | $0.28 | $0.38 | $1.12 | $0.79 | |||||||||||
Effect of adjustments to net income | $0.12 | $0.11 | $0.11 | $0.30 | $0.23 | |||||||||||
Diluted non-GAAP earnings per common share | $0.46 | $0.40 | $0.49 | $1.42 | $1.02 | |||||||||||
1 Includes product line impairment charges of
Includes Jetalon intangible impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
Includes product line impairment charge of
2The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005223/en/
Source:
Entegris, Inc.
Bill Seymour, +1 978-436-6500
VP of Investor
Relations
irelations@entegris.com